GelStat Corporation
Unique pain medication hits over-the-counter market
Published in Drug Law Weekly, May 17th, 2005
GelStat Arthritis is the company's second over-the-counter product and, like GelStat Migraine, utilizes the company's patent pending formulation in combination with a sublingual (under the tongue) delivery system.
"GelStat is committed to the development and commercialization of advanced OTC medications for the safe and effective treatment of pain and inflammation," said Stephen Roberts, MD, chairman and chief executive officer of GelStat. "Since inception, our research has focused on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2005-05-17)
More Articles from Drug Law Weekly
- Adventrx Pharmaceuticals, Inc.
Clearance granted in U.K. for CoFactor phase IIb colorectal cancer trial - Cardiology Hospital, Lille
Reports add new data to cardiology research - Caversham Group Practice, London
Who needs healthcare - the well or the sick? - Cierra, Inc.
Company reports first successful nonimplant cardiac catheter PFO closure - Eli Lilly and Company
U.S. District Court upholds Lilly's 2011 patent on Zyprexa for bipolar disorder - Henry J. Kaiser Family Foundation
Survey finds 4 in 10 seniors do not take medications as prescribed - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
